Literature DB >> 15295032

Identification of ectodomain regions contributing to gating, deactivation, and resensitization of purinergic P2X receptors.

Hana Zemkova1, Mu-Lan He, Taka-aki Koshimizu, Stanko S Stojilkovic.   

Abstract

The P2X receptors (P2XRs) are a family of ligand-gated channels activated by extracellular ATP through a sequence of conformational transitions between closed, open, and desensitized states. In this study, we examined the dependence of the activity of P2XRs on ectodomain structure and agonist potency. Experiments were done in human embryonic kidney 293 cells expressing rat P2X2aR, P2X2bR, and P2X3R, and chimeras having the V60-R180 or V60-F301 ectodomain sequences of P2X3R instead of the I66-H192 or I66-Y310 sequences of P2X2aR and P2X2bR. Chimeric P2X2a/V60-F301X3R and P2X2b/V60-F301X3R inherited the P2X3R ligand-selective profile, whereas the potency of agonists for P2X2a/V60-R180X3R was in between those observed at parental receptors. Furthermore, P2X2a/V60-F301X3R and P2X2a/V60-R180X3R desensitized in a P2X2aR-specific manner, and P2X2b/V60-F301X3R desensitized with rates comparable with those of P2X2bR. In striking contrast to parental receptors, the rates of decay in P2X2a/V60-F301X3R and P2X2b/V60-F301X3R currents after agonist withdrawal were 15- to 200-fold slower. For these chimeras, the decays in currents were not dependent on duration of stimuli and reflected both continuous desensitization and deactivation of receptors. Also, participation of deactivation in closure of channels inversely correlated with potency of agonists to activate receptors. The delay in deactivation was practically abolished in P2X2a/V60-R180X3R-expressing cells. However, the recovery from desensitization of P2X2a/V60-F301X3R and P2X2a/V60-R180X3R was similar and substantially delayed compared with that of parental receptors. These results indicate that both ectodomain halves participate in gating, but that the C and N halves influence the stability of open and desensitized conformation states, respectively, which in turn reflects on rates of receptor deactivation and resensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15295032      PMCID: PMC6729606          DOI: 10.1523/JNEUROSCI.1471-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Allosteric control of gating and kinetics at P2X(4) receptor channels.

Authors:  B S Khakh; W R Proctor; T V Dunwiddie; C Labarca; H A Lester
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

Review 2.  International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.

Authors:  B S Khakh; G Burnstock; C Kennedy; B F King; R A North; P Séguéla; M Voigt; P P Humphrey
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

Review 3.  Extracellular metabolism of ATP and other nucleotides.

Authors:  H Zimmermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

4.  Channel opening locks agonist onto the GABAC receptor.

Authors:  Y Chang; D S Weiss
Journal:  Nat Neurosci       Date:  1999-03       Impact factor: 24.884

5.  Agonist-stimulated internalisation of the ligand-gated ion channel P2X(1) in rat vas deferens.

Authors:  S J Ennion; R J Evans
Journal:  FEBS Lett       Date:  2001-02-02       Impact factor: 4.124

6.  A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X(2) ATP-gated channels.

Authors:  E Boué-Grabot; V Archambault; P Séguéla
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

7.  Pore dilation of neuronal P2X receptor channels.

Authors:  C Virginio; A MacKenzie; F A Rassendren; R A North; A Surprenant
Journal:  Nat Neurosci       Date:  1999-04       Impact factor: 24.884

8.  Mutation of histidine 286 of the human P2X4 purinoceptor removes extracellular pH sensitivity.

Authors:  C E Clarke; C D Benham; A Bridges; A R George; H J Meadows
Journal:  J Physiol       Date:  2000-03-15       Impact factor: 5.182

9.  Contributions of the C-terminal domain to the control of P2X receptor desensitization.

Authors:  T Koshimizu; M Koshimizu; S S Stojilkovic
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

10.  Modulatory activity of extracellular H+ and Zn2+ on ATP-responses at rP2X1 and rP2X3 receptors.

Authors:  S S Wildman; B F King; G Burnstock
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

View more
  18 in total

1.  The expression and role of hyperpolarization-activated and cyclic nucleotide-gated channels in endocrine anterior pituitary cells.

Authors:  Karla Kretschmannova; Marek Kucka; Arturo E Gonzalez-Iglesias; Stanko S Stojilkovic
Journal:  Mol Endocrinol       Date:  2011-12-01

Review 2.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

3.  Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors.

Authors:  Liana Asatryan; Maya Popova; John J Woodward; Brian F King; Ronald L Alkana; Daryl L Davies
Journal:  Neuropharmacology       Date:  2008-06-29       Impact factor: 5.250

4.  Characterization of purinergic P2X4 receptor channels expressed in anterior pituitary cells.

Authors:  Hana Zemkova; Marek Kucka; Shuo Li; Arturo E Gonzalez-Iglesias; Melanija Tomic; Stanko S Stojilkovic
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

Review 5.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 6.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

7.  The mechanism by which ethanol inhibits rat P2X4 receptors is altered by mutation of histidine 241.

Authors:  Keming Xiong; Xiang-Qun Hu; Randall R Stewart; Forrest F Weight; Chaoying Li
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 8.  Purinergic signaling pathways in endocrine system.

Authors:  Ivana Bjelobaba; Marija M Janjic; Stanko S Stojilkovic
Journal:  Auton Neurosci       Date:  2015-04-25       Impact factor: 3.145

9.  The penultimate arginine of the carboxyl terminus determines slow desensitization in a P2X receptor from the cattle tick Boophilus microplus.

Authors:  Selvan Bavan; Louise Farmer; Shire K Singh; Volko A Straub; Felix D Guerrero; Steven J Ennion
Journal:  Mol Pharmacol       Date:  2011-01-06       Impact factor: 4.436

10.  Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin.

Authors:  Irena Jelínkova; Vojtech Vávra; Marie Jindrichova; Tomas Obsil; Hana W Zemkova; Hana Zemkova; Stanko S Stojilkovic
Journal:  Pflugers Arch       Date:  2008-04-22       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.